Skip to main content
. 2018 Feb 16;12(2):273–281. doi: 10.1177/1932296818757747

Figure 2.

Figure 2.

Scheme of T1D S2017 highlighting the introduced upgrades. Specifically, the model incorporates time-varying parameters describing intraday SI variability (kp3, Vmx) and dawn phenomenon (kp1, kir); insulin delivery routes account for administration of subcutaneous fast-acting insulin, intradermal and inhaled insulins; glucose monitoring devices include models of both CGM and SMBG.